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Abstract
Background: Cancer makes up a large and increasing proportion of excess mortality for indigenous, marginalised
and socioeconomically deprived populations, and much of this inequality is preventable. This study aimed to
determine which cancers give rise to changing ethnic inequalities over time.
Methods: New Zealand census data from 1981, 1986, 1991, 1996, 2001, and 2006, were all probabilistically linked
to three to five subsequent years of mortality (68 million person-years) and cancer registrations (87 million person
years) and weighted for linkage bias. Age-standardised rate differences (SRDs) for Māori (indigenous) and Pacific
peoples, each compared to European/Other, were decomposed by cancer type.
Results: The absolute size and percentage of the cancer contribution to excess mortality increased from 1981–86
to 2006–11 in Māori males (SRD 72.5 to 102.0 per 100,000) and females (SRD 72.2 to 109.4), and Pacific females
(SRD −9.8 to 42.2) each compared to European/Other.
Specifically, excess mortality (SRDs) increased for breast cancer in Māori females (linear trend p < 0.01) and prostate
(p < 0.01) and colorectal cancers (p < 0.01) in Māori males. The incidence gap (SRDs) increased for breast (Māori and
Pacific females p < 0.01), endometrial (Pacific females p < 0.01) and liver cancers (Māori males p = 0.04), and for
cervical cancer it decreased (Māori females p = 0.03). The colorectal cancer incidence gap which formerly favoured
Māori, decreased for Māori males and females (p < 0.01).
The greatest contributors to absolute inequalities (SRDs) in mortality in 2006–11 were lung cancer (Māori males
50 %, Māori females 44 %, Pacific males 81 %), breast cancer (Māori females 18 %, Pacific females 23 %) and
stomach cancers (Māori males 9 %, Pacific males 16 %, Pacific females 20 %). The top contributors to the ethnic
gap in cancer incidence were lung, breast, stomach, endometrial and liver cancer.
Conclusions: A transition is occurring in what diseases contribute to inequalities. The increasing excess incidence
and mortality rates in several obesity- and health care access-related cancers provide a sentinel warning of the
emerging drivers of ethnic inequalities. Action to further address inequalities in cancer burden needs to be multi-
pronged with attention to enhanced control of tobacco, obesity, and carcinogenic infectious agents, and focus on
addressing access to effective screening and quality health care.
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Background
Indigenous, marginalised and socioeconomically de-
prived populations in countries around the world experi-
ence greater levels of premature mortality than their
counterparts (henceforth termed excess mortality). Can-
cer contributes to a large and increasing proportion of
this excess mortality [1, 2]. A substantial proportion of
inequalities in cancer are considered to be preventable
through the control of tobacco, obesity, alcohol and in-
fectious diseases [3], with further gains likely to be rea-
lised through equal access and quality of health care [4].
Changes in risk factor prevalence and cancer detection
and treatment have been associated with declines in can-
cer mortality rates in many countries, however not all
ethnic groups have benefited equally.
Several studies document the extent of ethnic and in-
digenous inequalities in cancer incidence and mortality
[5, 6] and explore trends in inequalities over time [7, 8].
Much of the excess cancer incidence and mortality ob-
served in indigenous and ethnic minority groups is due
to causes associated with poverty and social exclusion,
particularly tobacco smoking, chronic infections, obesity
and lower screening coverage [4]. However, the relative
importance of these more proximal causes of cancer
change over time, potentially requiring changes in the
emphasis of policies aimed at addressing inequities in
cancer outcomes.
These issues are relevant in New Zealand, where the
prevalence of tobacco smoking, obesity, human papil-
loma virus (HPV) infection, H. Pylori infection and
chronic hepatitis B infection is substantially higher in
Māori and Pacific peoples compared with European/
Other, and screening coverage rates are lower and vary
over time (Fig. 1). Such large ethnic differences in risk
factors makes New Zealand a potentially valuable case
study to explore the trends in ethnic inequalities in can-
cer burden.
A major challenge in examining ethnic inequalities in
cancer and other diseases is the inconsistent collection
of ethnicity data across datasets [9]. One way to address
this issue is to individually link census and cancer data
[8]. The linkage of census and cancer registration data in
New Zealand allows a rigorous analysis providing a com-
mon measure of ethnicity across cancer datasets and
census denominators that avoids (usually) underestima-
tion of cancer rates in the indigenous population [10].
Cancer is the most common cause of mortality in New
Zealand, an ethnically diverse high-income country
(75 % of the New Zealand population identified as Euro-
pean in the 2013 census, 15 % as Māori the indigenous
population, 12 % Asian and 7 % Pacific, where each indi-
vidual can identify with one or more ethnic groups).
Māori and Pacific peoples experience greater socioeco-
nomic deprivation, greater cancer mortality and greater
all-cause mortality than European/Other. Māori and Pa-
cific mortality has generally declined in the 2000s [11],
but inequalities compared to European/Other remain
high.
Our aim was first to quantify the contribution of can-
cer to overall ethnic gaps in all-cause mortality over time
in the New Zealand population. Second, we aimed to
measure the contribution of individual cancers to the
overall ethnic gaps in cancer mortality. Third, we aimed
to estimate the contribution of changes in cancer inci-
dence to trends in ethnic inequalities in mortality.
Methods
Data linkage
New Zealand mortality and Cancer Registry data were
probabilistically linked with five-yearly censuses of popu-
lation and dwellings. The population-based cancer regis-
ter collects information on all malignant tumours
(except basal and squamous cell skin cancers) with
mandatory notification since 1994 (1993 Cancer Registry
Act) and high compliance. Six closed cohorts were cre-
ated of the New Zealand usual resident population (all
ages) on census nights in 1981, 1986, 1991, 1996, 2001,
2006 and these populations were followed up for 5 years
for incident deaths (2001–06 and 2006–11 cohorts) and
3 years for the earlier cohorts. Follow-up of incident
cancer(s) was for 5 years, or in the case of the 2001 cen-
sus, until 31 December 2004 (due to the timing of previ-
ous record linkage study). The probabilistic record
linkage was done with QualityStage software using an
individual’s address (meshblock or census area unit), sex,
date of birth, ethnicity, and country of birth as matching
variables. This provided 300 285 incident cancers arising
from 87.3 million person-years of follow-up (1981–86 to
2006–11), and 87 606 cancer deaths from 67.9 million
person-years of follow-up (1981–84 to 2006–11).
The percentage of deaths linked to a census record
ranged from 71 % (1981 mortality linkage) [12] to 83 %
(2006 registration linkage) [13]. Therefore, all linked
census-cancer records were weighted up to be representa-
tive of all eligible cancers, using the inverse of the prob-
ability of being linked. For example, if only 20 out of 25
eligible cancers for Māori males aged 50–54 years old of
high deprivation living in the north of New Zealand, were
linked back to their census record, each of the 20 linked
records was weighted up by 25/20 = 1.25. This adjusts for
underestimation of rates using the linked datasets, and
corrects for any linkage bias where the percentage of eli-
gible cancer records linked varied by ethnicity. Further de-
tails are published elsewhere [14].
Ethnicity and selected cancers
If individuals self-identified as Māori, Pacific and/or
Asian ethnic groups, they were assigned to all the groups
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to which they identified; a total response ethnicity ap-
proach [15]. The remaining group that did not iden-
tify as Māori, Pacific or Asian was assigned to be
European/Other, used in this study as the comparator.
The 1981 census question was based on ethnic origin
(rather than affiliation). To be consistent with later
census years, someone was classified as Māori if they
self-reported any Māori origin (likewise for Pacific
and Asian). Analyses for the Asian population were
limited by small numbers so they are presented in
Additional file 1.
We present data on total cancer incidence and total
cancer mortality. Furthermore nine cancers were se-
lected from a wider list of 25 primary cancers. Coding
was according to the International Classification of Dis-
ease (ICD 9 and 10). Stomach (C16), colorectal (C18-
20), liver (C22), lung (C34), melanoma (C43), breast
(C50), cervix (C53), endometrial (C54) and prostate
(C61) cancers were selected because the incidence rate
differences were statistically significant in at least four
out of six cohorts for either sex for at least one of Māori
or Pacific compared to European/Other ethnic group.
Mortality rate differences were presented for all these
cancers except for endometrial, cervical and liver can-
cer mortality where there was a smaller number of
deaths. Incidence observations were censored upon
the occurrence of the first relevant cancer. We could
not censor for non-cancer mortality and out migra-
tion because census-cancer and census-mortality data-
sets were not linked in earlier cohorts. In the 2006–
11 cohort, however, we did censor for non-cancer
mortality.
The major risk factors for the cancers selected in our
study were tobacco (lung cancer), infectious agents
(stomach and liver cancer), obesity (endometrial and
postmenopausal breast cancer, and to a lesser extent for
colorectal cancer) and access to screening and treatment
(cervical, prostate [16], and melanoma cancers) [3].
Changing reproductive patterns associated with access
to contraception and later child bearing, may also be
drivers of increasing breast cancer rates. Colorectal
screening has been little used in New Zealand to date
and is unlikely to have had much impact on incidence or
mortality. Alcohol consumption is a risk factor for liver,
breast and colorectal cancers [17, 18].
Analysis
Direct age-standardisation was applied, using the WHO
World Standard Population to maximise international
comparability. Standardised rates were calculated in 1–
74 year olds for each ethnic group in each cohort (num-
ber of events per person-years of follow-up). Standar-
dised rate differences (SRDs) and standardised rate
ratios (SRRs) were calculated for Māori and Pacific com-
pared to European/Other. We present absolute (SRDs)
and relative measures of inequality (SRRs). Absolute
measures were presented in stacked diagrams because
these measures are less prone to be misleading for clin-
ical practice and public policy [19], and are more pliable
to decompose absolute inequalities by cancer type.
Statistical tests of increasing or decreasing linear trend
(linear regression) were calculated on log rates, log rate
ratios and rate differences, using the mid-date of each
cohort period as the independent variable. Analysis was
done using SAS V.9.4 (SAS Institute Inc, Cary, North
Carolina, USA).
Results
Ethnic inequalities in cancer mortality
All-cause mortality declined for all ethnic groups across
all six cohorts from 1981–84 to 2006–11. However, eth-
nic inequalities in all-cause mortality remained and were
comprised of cardiovascular disease, cancer and other
causes. The contribution of cancer to all-cause mortality
inequalities increased (both in absolute and percentage
terms) for Māori males and females, and Pacific females
each compared to European/Other (the stacked height
of ‘All cancer’ in Fig. 2). For example, inequalities (SRD)
in cancer mortality between Māori and European/Other
females comprised 19 % of all-cause mortality inequal-
ities in the 1981–84 cohort (SRD 72.5/389.5 per 100
000) but increased substantially in the 2006–11 cohort
(to 34 %, SRD 102.0/300.7 per 100 000).
Table 1 shows ethnic inequalities in cancer mortality
increased from 1981 to 2011 particularly in females. For
example, in the 2006–11 cohort, the overall mortality
rate from cancer was 202.0 per 100 000 Māori females
and 92.6 in European/Other, an overall SRD of 109.4
excess deaths per 100 000 (Table 1; and the net height of
the 2006–11 bar in Fig. 3, SRD= 114 – 5). From 1981–84
to 2006–11 the cancer mortality in European/Other females
(See figure on previous page.)
Fig. 1 Ethnic inequalities in smoking, obesity, alcohol and screening examples of mediators for excess cancer mortality, New Zealand. Note:
Smoking prevalence rates use the definition of regular current smoking of 1+ cigarette per day and there was some slight variation between
censuses in the questions for ethnicity and smoking. The crude obesity prevalence rates from National Nutrition Surveys (NNS) and New Zealand
Health Surveys (NZHS) use an obesity definition of a BMI of ≥30, except for Māori and Pacific peoples before 2000 when it was ≥32. The age
group was 15+ year olds except for in 1977 (20–64 years) and 1989 (15–74 years). European/Other obesity figures in 1977 and 1989 are estimated
from the total population. Alcohol consumption is from the NZHS and the New Zealand Drug and Alcohol Survey. Breast and cervical screening
coverage is from the Independent Monitoring Reports at www.nsu.govt.nz
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decreased significantly from 110.6 to 92.6 per 100 000
population (p = 0.01) but the cancer mortality rate for
Māori females appeared to have increased (182.8 to
202.0, p = 0.09). Subsequently, absolute inequalities
(SRD) for Māori females increased from 72.2 to 109.4
deaths per 100 000 (p = 0.01) (Table 1; and the net
height of the bars in Fig. 3). There was a similar increase
in inequalities for Pacific females (SRDs −9.8 to 42.2,
p = 0.03) and some suggestive increase for Māori males
(72.5 to 102.0, p = 0.17).
Contribution of individual cancers to ethnic inequalities in
mortality
The pattern of cancers contributing to absolute in-
equalities in mortality varied by sex, ethnicity and by
time (Table 1). In Māori males for example, the stan-
dardised mortality rate from lung cancer was 71.2 per
100 000 compared to only 20.5 per 100 000 in Euro-
pean/Other males in the 2006–11 cohort; excess mor-
tality of 50.7 per 100 000 (Fig. 3). Thus the greatest
contributors to Māori male cancer mortality SRDs
were lung cancer (50 % of the total), stomach cancer
(SRD: 9.4 per 100 000, 9 %), and prostate cancer
(SRD: 9.2 per 100 000, 9 %) (Table 1, Fig. 3). For Pa-
cific males, the largest contributors were lung cancer
(SRD: 29.4 per 100 000, 81 %) and stomach cancer
(SRD: 5.8 per 100 000, 16 %); for Māori females it
was lung cancer (48.5 per 100 000, 44 %) and breast
cancer (19.6 per 100 000, 18 %); and for Pacific fe-
males it was breast cancer (9.7 per 100 000, 23 %)
and stomach cancer (8.5 per 100 000, 20 %).
The absolute contribution of individual cancer types
to ethnic inequalities in mortality changed significantly
from the 1981–84 to the 2006–11 cohort (Table 1,
Fig. 3). The SRD from lung cancer mortality peaked in
the 1996–99 cohort in Māori males and the 2001–06 co-
hort in Māori females, and was a significant contributor
throughout the study period. Pacific males had increas-
ing rates of excess lung cancer mortality, changing from
lower rates than European/Other in 1981–84 (SRD
Fig. 2 Contribution of cancer and cardiovascular disease (CVD) to ethnic inequalities in all-cause mortality over time for Māori and Pacific peoples
(compared to the European/Other population) 1–74 years old in New Zealand, census-linked mortality data for six cohorts between 1981
and 2011
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Table 1 Trends in the absolute ethnic inequalities in cancer incidence and mortality in Māori and Pacific males and females compared to European/Other, New Zealand census-












Rate difference (CI) Linear
trend
p-value
Rate ratio (CI) Rate Linear
trend
p-value





Lung 1981–84 44.5 . 87.8 . 43.4 (24.4 to 62.4) . 1.98 (1.58–2.47) 23.5 . −21.0 (−39.1– −2.9) . 0.53 (0.25–1.14)
2006–11 20.5 <0.01 71.2 0.07 50.7 (42.6–58.8) 0.87 3.47 (3.06–3.94) 49.9 0.30 29.4 (17.9–40.9) 0.07 2.43 (1.92–3.08)
Colorectal 1981–84 22.5 . 13.7 . −8.8 (−15.5– −2.2) . 0.61 (0.38–0.98) 7.5 . −15.0 (−25.6– −4.4) . 0.33 (0.08–1.35)
2006–11 17.4 0.05 20.4 0.15 3.1 (−1.1–7.3) <0.01 1.18 (0.96–1.45) 9.4 0.68 −7.9 (−11.8– −4.0) 0.10 0.54 (0.36–0.81)
Prostate 1981–8 9.1 . 8.8 . −0.3 (−7.6–7.0) . 0.97 (0.42–2.21) 26.2 . 17.1 (−14.5–48.6) . 2.87 (0.85–9.63)
2006–11 9.3 0.86 18.5 0.01 9.2 (4.8–13.7) <0.01 1.99 (1.55–2.56) 10.0 0.23 0.7 (−4.7–6.1) 0.32 1.07 (0.62–1.85)
Stomach 1981–84 8.7 . 24.3 . 15.6 (6.2–25.0) . 2.80 (1.87–4.20) 35.2 . 26.6 (−1.5–54.6) . 4.07 (1.82–9.10)
2006–11 3.8 <0.01 13.2 0.15 9.4 (6.1–12.7) 0.57 3.47 (2.62–4.59) 9.7 0.04 5.8 (1.1–10.6) 0.07 2.53 (1.53–4.18)
Melanoma 1981–84 5.6 . 0.8 . −4.8 (−6.6– −3.1) . 0.14 (0.02–0.97) . . . . .
2006–11 7.1 . 1.9 . −5.1 (−6.6– −3.6) . 0.28 (0.14–0.54) 1.6 . −5.5 (−7.2– −3.7) . 0.23 (0.08–0.61)
All cancers 1981–84 147.2 . 219.7 . 72.5 (43.5–101.4) . 1.49 (1.31–1.71) 173.3 . 26.1 (−31.0–83.1) . 1.18 (0.85–1.64)
2006–11 112.2 <0.01 214.3 0.66 102.0 (88.1–116.0) 0.17 1.91 (1.78–2.04) 148.4 0.20 36.2 (17.5–54.9) 0.94 1.32 (1.17–1.50)
Incidence
Lung 1981–86 50.9 . 91.2 . 40.3 (26.7 to 54.0) . 1.79 (1.54 to 2.09) 56.5 . 5.7 (−26.1 to 37.4) . 1.11 (0.63 to 1.95)
2006–11 25.6 <0.01 78.9 0.08 53.3 (44.8 to 61.8) 0.69 3.08 (2.74 to 3.47) 49.3 0.15 23.7 (12.3 to 35.2) 0.70 1.93 (1.52 to 2.44)
Colorectal 1981–86 48.8 . 24.5 . −24.3 (−32.1 to −16.4) . 0.50 (0.37 to 0.69) 22.3 . −26.5 (−40.1 to −12.9) . 0.46 (0.25 to 0.84)
2006–11 47.4 0.76 42.9 <0.01 −4.5 (−10.7 to 1.8) <0.01 0.91 (0.78 to 1.05) 29.8 0.94 −17.6 (−26.0 to −9.3) 0.89 0.63 (0.48 to 0.83)
Prostate 1981–86 27.7 . 32.7 . 5.0 (−5.5 to 15.5) . 1.18 (0.86 to 1.63) 20.7 . −7.0 (−30.0 to 16.0) . 0.75 (0.25 to 2.27)
2006–11 110.1 <0.01 101.0 <0.01 −9.1 (−18.8 to 0.6) 0.11 0.92 (0.83 to 1.01) 88.2 0.01 −21.9 (−36.6 to −7.2) 0.07 0.80 (0.68 to 0.95)
Stomach 1981–86 11.5 . 18.9 . 7.4 (1.8 to 13.1) . 1.65 (1.21 to 2.24) 50.1 . 38.6 (8.6 to 68.6) . 4.37 (2.38 to 8.00)
2006–11 5.5 <0.01 18.7 0.44 13.2 (9.2 to 17.2) 0.53 3.42 (2.69 to 4.34) 15.0 0.13 9.6 (4.2 to 14.9) 0.31 2.75 (1.89 to 3.99)
Melanoma 1981–86 21.1 . 6.4 . −14.7 (−18.0 to −11.5) . 0.30 (0.19 to 0.48) 3.6 . −17.5 (−21.8 to −13.2) . 0.17 (0.06 to 0.53)
2006–11 53.3 <0.01 8.0 0.11 −45.3 (−48.3 to −42.2) <0.01 0.15 (0.11 to 0.20) 3.2 0.78 −50.1 (−53.0 to −47.2) <0.01 0.06 (0.03 to 0.12)
Liver* 1981–86 1.5 . 8.7 . 7.3 (3.8 to 10.8) . 5.95 (3.73 to 9.51) 16.3 . 14.8 (7.1 to 22.6) . 11.12 (6.51 to 19.0)
2006–11 3.8 0.01 16.5 0.02 12.8 (9.4 to 16.1) 0.04 4.39 (3.46 to 5.58) 19.3 0.82 15.5 (8.9 to 22.1) 0.64 5.12 (3.55 to 7.38)
First cancers^ 1981–86 271.2 . 309.0 . 37.8 (12.2 to 63.3) . 1.14 (1.05 to 1.24) 324.8 . 53.6 (−12.7 to 119.9) . 1.20 (0.98 to 1.47)











Table 1 Trends in the absolute ethnic inequalities in cancer incidence and mortality in Māori and Pacific males and females compared to European/Other, New Zealand census-
linked mortality data 1981–2011 (Continued)
European/Other
females
Māori females Pacific females






Rate difference (CI) Linear
trend
p-value
Rate ratio (CI) Rate Linear
trend
p-value





Lung 1981–84 12.1 . 55.7 . 43.7 (29.0–58.3) . 4.62 (3.49–6.12) 6.1 . −5.9 (−13.1–1.2) . 0.51 (0.16–1.62)
2006–11 16.1 . 64.6 . 48.5 (41.8–55.2) . 4.01 (3.56–4.52) 20.4 . 4.3 (−1.5–10.0) . 1.26 (0.95–1.68)
Colorectal 1981–84 19.3 . 6.7 . −12.6 (−17.4– −7.8) . 0.35 (0.18–0.68) 3.5 . −15.8 (−21.4– −10.2) . 0.18 (0.04–0.85)
2006–11 13.6 . 11.4 . −2.2 (−5.4–1.0) . 0.84 (0.64–1.11) 10.0 . −3.6 (−7.7–0.5) . 0.74 (0.49–1.11)
Breast 1981–84 25.6 . 31.3 . 5.7 (−4.0–15.3) . 1.22 (0.89–1.67) 18.7 . −6.9 (−21.4–7.5) . 0.73 (0.34–1.57)
2006–11 18.2 <0.01 37.8 <0.01 19.6 (14.5–24.6) <0.01 2.07 (1.80–2.39) 27.9 0.53 9.7 (3.3–16.1) 0.13 1.53 (1.21–1.94)
Stomach 1981–84 3.5 . 13.3 . 9.8 (3.8–15.9) . 3.80 (2.33–6.18) 10.7 . 7.2 (−5.3–19.7) . 3.05 (0.94–9.89)
2006–11 1.6 . 9.4 . 7.8 (5.4–10.3) . 5.88 (4.26–8.13) 10.1 . 8.5 (4.3–12.6) . 6.30 (4.00–9.92)
Melanoma 1981–84 3.5 . 0.4 . −3.1 (−4.2– −2.0) . 0.12 (0.02–0.86) 1.6 . −1.9 (−5.2–1.4) . 0.46 (0.06–3.31)
2006–11 3.6 . 0.9 . −2.7 (−3.5– −1.9) . 0.25 (0.12–0.51) 0.7 . −2.9 (−4.0– −1.9) . 0.19 (0.05–0.76)
All cancers^ 1981–84 110.6 . 182.8 . 72.2 (47.5–97.0) . 1.65 (1.44–1.90) 100.8 . −9.8 (−46.3–26.8) . 0.91 (0.63–1.31)
2006–11 92.6 <0.01 202.0 0.09 109.4 (97.4–121.4) 0.01 2.18 (2.05–2.32) 134.8 0.08 42.2 (27.4–57.0) 0.03 1.46 (1.30–1.63)
Incidence
Lung 1981–86 14.9 . 45.7 . 30.9 (21.4 to 40.3) . 3.08 (2.48 to 3.82) 9.1 . −5.7 (−12.0 to 0.5) . 0.61 (0.31 to 1.21)
2006–11 21.0 0.02 74.3 0.07 53.3 (46.1 to 60.5) 0.09 3.53 (3.17 to 3.94) 23.4 0.03 2.4 (−3.9 to 8.6) 0.07 1.11 (0.85 to 1.46)
Colorectal 1981–86 43.1 . 18.5 . −24.6 (−30.0 to −19.2) . 0.43 (0.33 to 0.57) 24.5 . −18.5 (−33.0 to −4.0) . 0.57 (0.32 to 1.03)
2006–11 37.8 0.21 24.6 0.05 −13.2 (−17.5 to −8.8) <0.01 0.65 (0.55 to 0.77) 20.5 0.75 −17.3 (−23.1 to −11.4) 0.21 0.54 (0.41 to 0.72)
Breast 1981–86 69.4 . 69.1 . −0.3 (−10.7 to 10.1) . 1.00 (0.86 to 1.16) 67.5 . −1.9 (−22.4 to 18.5) . 0.97 (0.72 to 1.32)
2006–11 95.8 0.03 140.1 <0.01 44.3 (35.2 to 53.4) <0.01 1.46 (1.37 to 1.57) 116.0 0.05 20.2 (7.6 to 32.8) 0.40 1.21 (1.09 to 1.35)
Stomach 1981–86 4.9 . 14.7 . 9.8 (5.0 to 14.6) . 2.98 (2.10 to 4.22) 15.9 . 11.0 (−1.3 to 23.3) . 3.23 (1.47 to 7.07)
2006–11 2.3 <0.01 13.6 0.96 11.3 (8.4 to 14.2) 0.32 5.84 (4.47 to 7.64) 8.7 0.14 6.4 (2.6 to 10.2) 0.34 3.73 (2.35 to 5.93)
Melanoma 1981–86 29.2 . 6.2 . −23.0 (−26.2 to −19.8) . 0.21 (0.14 to 0.33) 4.1 . −25.2 (−30.0 to −20.3) . 0.14 (0.05 to 0.43)
2006–11 48.8 <0.01 7.7 0.23 −41.1 (−43.8 to −38.4) <0.01 0.16 (0.12 to 0.20) 2.5 0.54 −46.4 (−48.9 to −43.9) <0.01 0.05 (0.03 to 0.10)
Liver* 1981–86 0.9 . 6.8 . 5.8 (1.1 to 10.5) . 7.23 (3.38 to 15.5) 4.6 . 3.7 (−1.5 to 8.9) . 4.93 (1.53 to 15.9)
2006–11 1.5 . 4.6 . 3.1 (1.5 to 4.8) . 3.14 (2.08 to 4.74) 3.8 . 2.4 (−0.2 to 4.9) . 2.62 (1.32 to 5.22)
Cervix* 1981–86 11.9 . 39.8 . 27.9 (19.6 to 36.2) . 3.35 (2.67 to 4.19) 25.1 . 13.2 (1.9 to 24.4) . 2.11 (1.34 to 3.32)











Table 1 Trends in the absolute ethnic inequalities in cancer incidence and mortality in Māori and Pacific males and females compared to European/Other, New Zealand census-
linked mortality data 1981–2011 (Continued)
Endometrial* 1981–86 11.8 . 18.6 . 6.8 (1.9 to 11.8) . 1.58 (1.20 to 2.07) 22.9 . 11.1 (−1.7 to 23.9) . 1.94 (1.10 to 3.41)
2006–11 12.6 0.25 27.5 0.17 14.9 (10.7 to 19.1) 0.20 2.18 (1.85 to 2.57) 49.8 <0.01 37.2 (29.1 to 45.3) <0.01 3.95 (3.31 to 4.71)
First cancers^ 1981–86 258.0 . 308.0 . 50.0 (27.0 to 73.0) . 1.19 (1.11 to 1.29) 277.3 . 19.2 (−26.3 to 64.8) . 1.07 (0.91 to 1.27)
2006–11 344.7 0.01 419.9 <0.01 75.2 (58.5 to 91.9) 0.22 1.22 (1.17 to 1.27) 335.1 0.09 −9.6 (−32.0 to 12.9) 0.33 0.97 (0.91 to 1.04)
Note: *For liver cancer only incidence data were available due to small numbers in mortality data. ^Incidence is first cancer incidence in the follow-up period, mortality is any cancer mortality in the follow-up period.
All rates, rate differences and rate ratios are age-standardised using the WHO World Standard Population. Cancers were selected for inclusion if they had a significant incidence rate difference in an ethnic comparison











−21.0 per 100 000) to higher in the 2006–11 cohort
(SRD 29.4 per 100 000; p-value for linear trend = 0.07).
In Pacific females there was a similar but lower magni-
tude transition of SRDs from −5.9 to 4.3 per 100 000.
The breast cancer mortality SRD for Māori females in-
creased from 5.7 per 100 000 in the 1981–84 cohort to
19.6 in 2006–11 (p < 0.01). There was also a suggestive
increase for Pacific females, from a negative difference
Fig. 3 Decomposition of absolute ethnic inequalities in cancer mortality by major contributing cancer types, comparing Māori and Pacific
peoples with European/Other in males and females aged 1–74 years in New Zealand. *Note some cancer types are excluded due to
small numbers
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(−6.9 per 100 000) in 1981–84 to 9.7 per 100 000 in
2006–11 (p = 0.13).
Prostate cancer made an increasing contribution to ex-
cess Māori male mortality from a negative SRD (−0.3) in
the 1981–84 cohort to an excess of 9.2 per 100 000 in
2006–11 (p < 0.01).
Colorectal cancer for Māori males also changed from
a negative SRD (−8.8 per 100 000 in 1981–84) to an
excess of 3.1 per 100 000 in the 2006–11 cohort (p <
0.01). The colorectal cancer mortality SRDs were always
negative for Māori females, and Pacific males and fe-
males, but trended towards zero over time.
Stomach cancer made a decreasing contribution to excess
deaths among Māori and Pacific males from the 1981–84
to 2006–11 cohort, for example the SRD in Pacific males
decreased from 26.6 to 5.8 per 100 000 (p = 0.07).
Fig. 4 Trends in cancer incidence by ethnic group, males and females aged 1–74 years in New Zealand for six cohorts between 1981 and 2011
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Contribution of incidence to mortality trends
Ethnic inequalities in total cancer incidence varied sub-
stantially from the 1981–84 to the 2006–11 cohort.
Trends in cancer incidence by ethnicity are shown in
Fig. 4, and trends in cancer incidence SRDs in Fig. 5
(with data for endometrial, liver and cervical cancer, not
available for mortality trends due to small numbers).
The overall cancer incidence gap decreased for: Pacific
males (53.6 to −77.6, p = 0.02) and probably also so for
Māori males (37.8 to 25.3, p = 0.24) and Pacific females
(19.2 to −9.6, p = 0.33). But in Māori females the gap ap-
peared to increase (50.0 to 75.2 per 100 000, p = 0.22).
Fig. 5 Decomposition of absolute ethnic inequalities in cancer incidence by major contributing cancer types, comparing Māori and Pacific with
European/Other in males and females aged 1–74 years in New Zealand
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Melanoma contributed to a greater share of incidence
inequality trends than mortality trends. Similarly there
were diverging trends for prostate cancer mortality and
incidence where excess mortality increased (p < 0.01)
and the incidence gap appeared to decrease (p = 0.11).
Melanoma and prostate cancers aside, cancers contribut-
ing to the incidence gap were generally similar to the can-
cers contributing to excess mortality. Breast cancer
incidence increased in all ethnic groups but at a faster rate
in Māori and Pacific females thus widening the incidence
gap (SRD linear trend for both was p < 0.01). Protection
from colorectal cancer decreased for Māori males (p < 0.01)
and females (p < 0.01) as incidence increased in Māori to
levels similar to European/Other. Furthermore, among Pa-
cific females in the 2006–11 cohort, endometrial cancer
was the greatest contributor (SRD 37.2 per 100 000) to the
incidence gap, and the SRD increased from 11.1 to 37.2 be-
tween the 1981–86 and the 2006–11 cohort (p < 0.01), with
a similar trend in Māori females (SRD from 6.8 to 14.9, p =
0.20). In Pacific males liver cancer was the second greatest
contributor (15.5 per 100 000) to the incidence gap and its
contribution remained stable across time in all groups ex-
cept for Māori males for whom the gap increased from 7.3
(1981–86) to 12.8 (2006–11) (p = 0.04). There were also re-
ductions in the cervical cancer incidence gap in Māori
(SRD 27.9 to 9.2, p = 0.03) and Pacific females (13.2 to 4.7,
p = 0.08). Stomach and liver cancer accounted for the great-
est relative ethnic inequalities (SRRs) with three- to six-fold
greater incidence in Māori and Pacific populations com-
pared to European/Other (2006–11).
Discussion
This study found that inequalities in cancer mortality in-
creased in Māori males and females, Pacific females and
possibly in Pacific males each compared to European/
Other. This is similar to evidence of an increased contribu-
tion from cancer to socioeconomic inequalities in mortality
from Norway [1] and New Zealand [2]. A transition is oc-
curring in which particular diseases contribute to inequal-
ities. From the 1981–84 to the 2006–11 cohort excess
cancer mortality (SRDs) significantly increased for breast
cancer in Māori females, prostate and colorectal cancers in
Māori males, and there was a decreasing trend for stomach
cancer in Pacific males. There were significant increases in
the contribution (SRDs) of breast cancer (Māori and Pacific
females), endometrial cancer (Pacific females) and liver
cancer (Māori males) to the ethnic gap in cancer incidence,
while the cervical cancer contribution significantly de-
creased for Māori females. Furthermore, colorectal cancer
incidence in Māori males and females increased towards
the European/Other incidence thus significantly narrowing
the ethnic difference that was previously favouring Māori.
In the 2006–11 cohort, lung, breast and stomach cancers
made the largest contribution to mortality inequalities in
Māori and Pacific peoples, and the largest contributors to
the ethnic gap in cancer incidence were lung, breast,
stomach, endometrial and liver cancer.
Incidence drivers: smoking, obesity, alcohol, infection and
screening
The trends over time in cancer incidence and mortality,
and contribution of individual cancers to excess cancer
mortality (for Māori and Pacific) vary by cancer type, and
might best be understood by examining changes to the
mediating risk factors of tobacco, obesity, alcohol con-
sumption, carcinogenic infectious agents and access to
cancer screening (Fig. 1). While this study is of just one
high-income country, the implications are potentially rele-
vant to many other countries given the globally shared
patterns of epidemiological transitions and (to some ex-
tent) common social and ethnic inequalities in the deter-
minants of cancer inequalities.
Smoking-related gaps in lung cancer mortality between
Māori and European/Other are starting to diminish, but
these gaps continued to increase for Pacific males and fe-
males. These patterns align well with ethnic-group specific
trends in smoking prevalence (Fig. 1). But even for Māori,
the large lung cancer gap means that there is still much
more to be gained in terms of reducing ethnic inequalities
through enhanced tobacco control.
Absolute ethnic inequalities in cancer increased over
our study period for obesity-related breast and endomet-
rial cancers [3], and colorectal, prostate and liver cancers
where obesity may play a lesser role. The increasingly
higher rates of diabetes, physical inactivity and obesity
were calculated to explain 79 % of the endometrial can-
cer incidence gap for Pacific females compared to Euro-
pean/Other in the 2001–04 cohort [20]. Increasing
obesity-related cancer trends are consistent with at least
a decade of marked and widening ethnic disparities in
obesity (Fig. 1) and the contribution of obesity to in-
creased incidence trends in breast, endometrial, and
colorectal cancer in other countries [3]. Similar to our
study, in the United States (US) Non-Hispanic Black
population (compared to White) there were higher rates
of obesity [21], endometrial cancer (7.5 per 100 000 vs
4.0), breast cancer (30.6 vs 21.7), and also colorectal can-
cer incidence (male 27.7 vs 18.5, female 18.5 vs 13.0)
which we did not identify [22]. Greater policy attention
is required to constrain the obesogenic environment.
Total alcohol consumption does not differ much between
Māori and European/Other and differences by ethnicity
have not changed much over time (Fig. 1). European/Other
are more likely to have drunk alcohol in the last year but
Māori and Pacific (males only) have higher rates of hazard-
ous drinking patterns [23]. However, for Māori and Pacific
women there may be some suggestion that alcohol con-
sumption (in the last year) has increased over time to
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match European/Other and narrowed the gap (Fig. 1). This
may have contributed somewhat to the pattern of inequal-
ities observed for breast and colorectal cancer in women,
but it does not contribute to explaining the similar patterns
in men for colorectal cancer.
There is also more to be gained through addressing
ethnic inequalities and the burden of infection-related
cancers. Stomach and liver cancer make a large contri-
bution to absolute ethnic inequalities (stomach cancer
was the second greatest contributor to ethnic inequal-
ities in mortality for both Māori and Pacific males) and
accounted for the greatest relative ethnic inequalities
(SRRs). Additional measures to reduce stomach and liver
cancer are required, and may include screening and
treating for H. pylori infection [24]. Inequalities for
Māori males in liver cancer incidence increased over our
study period, likely relating to trends in chronic hepatitis
B infection – which should peak soon with the wide-
spread vaccination against hepatitis B from the late
1980s. The stomach cancer contribution to inequalities
somewhat decreased in Māori and Pacific males, paral-
leling declines elsewhere [22] and declines in H. pylori
infection [25] which is implicated in 89 % of distal stom-
ach cancer [26].
Trends in cervical and prostate inequalities are poten-
tially related to disparities in access to screening and
treatment services. Effective screening programmes with
equitable coverage can reduce excess cancer mortality,
with the substantial reduction of cervical cancer inequal-
ities seen in New Zealand being an example [27]. Abso-
lute inequalities in cervical cancer incidence have fallen
in parallel with recent data on closing inequalities in
screening coverage (Fig. 1) and (less importantly) declin-
ing smoking prevalence. Prostate cancer mortality in-
equalities increased and this is likely due to inequitable
access to detection and management [16] and perhaps
to a lesser extent increased consumption of animal fat,
obesity, and physical inactivity [3].
Whilst we do not directly quantify survival inequalities
in this paper, Māori have approximately one-third higher
deaths rates once diagnosed with cancer (due to comor-
bidities, later diagnosis and other factors) and there is
no evidence that ethnic inequalities in survival have
changed over time in New Zealand [28]. This contrasts
with the improvement reported for some such cancer
survival disparities by ethnicity in the US [29, 30].
Study strengths and limitations
The linkage of census and cancer and mortality registra-
tion data permitted a rigorous analysis of cancer trends
by ethnicity over a 30 year period for an entire national
population, free of numerator-denominator bias. Study
size was very large (87 million person-years of follow-up
for cancer incidence) but statistical precision was
sometimes limited, for example for Pacific generally and
individual cancers such as liver, endometrial and cervical
cancer. The ability to examine trends in both incidence
and mortality inequalities provided a valuable way to
evaluate the consistency of the cancer-specific trends. In
addition, mortality data is more robust as it does not rely
on diagnostic patterns that reflect clinician effort and
thresholds for investigation (for example prostate
cancer).
Conclusions
This study found increases in both the absolute size
and percentage of the cancer contribution to excess
mortality in Māori compared to European/Other. Some
reductions in ethnic inequalities in certain cancers are
likely to reflect decades of tobacco control measures
and improved cervical screening coverage in New Zea-
land. Tobacco use remained the greatest contributor to
inequalities and there were persistent absolute inequal-
ities in infection-related cancers. The increasing excess
incidence and mortality rates in several obesity- and
health care access-related cancers provide a sentinel
warning of the emerging drivers of ethnic inequalities.
Action to further address inequalities in cancer burden
needs to be multi-pronged with attention to enhanced
control of tobacco, obesity, alcohol, and carcinogenic
infectious agents, and focus on addressing access to ef-
fective screening and quality health care.
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